151.68
-0.38 (-0.25%)
| Previous Close | 152.06 |
| Open | 150.87 |
| Volume | 258,474 |
| Avg. Volume (3M) | 592,147 |
| Market Cap | 8,196,058,624 |
| Price / Sales | 4.06 |
| Price / Book | 9.24 |
| 52 Weeks Range | |
| Earnings Date | 5 May 2025 - 12 May 2025 |
| Profit Margin | -23.25% |
| Operating Margin (TTM) | 21.69% |
| Diluted EPS (TTM) | -5.46 |
| Quarterly Revenue Growth (YOY) | 9.50% |
| Quarterly Earnings Growth (YOY) | -7.50% |
| Total Debt/Equity (MRQ) | 72.01% |
| Current Ratio (MRQ) | 2.17 |
| Operating Cash Flow (TTM) | 181.70 M |
| Levered Free Cash Flow (TTM) | 139.68 M |
| Return on Assets (TTM) | 1.32% |
| Return on Equity (TTM) | -25.07% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Medical Devices (US) | Bearish | Mixed |
| Medical Devices (Global) | Bearish | Mixed | |
| Stock | Masimo Corporation | Bearish | Bullish |
AIStockmoo Score
| Analyst Consensus | 2.0 |
| Insider Activity | NA |
| Price Volatility | -2.0 |
| Technical Moving Averages | 1.0 |
| Technical Oscillators | 4.0 |
| Average | 1.25 |
|
Masimo Corp is a global technology company. The company's segment includes healthcare and non-healthcare. The healthcare business segment is a key revenue driver, develops, manufactures, and markets a variety of noninvasive patient monitoring technologies, hospital automation and connectivity solutions, remote monitoring devices and consumer health products. Its non-healthcare segment includes consumer audio business develops, manufactures, markets sells and licenses premium and luxury audio sound products and related integration technologies. |
|
| Sector | Healthcare |
| Industry | Medical Devices |
| Investment Style | Small Core |
| % Held by Insiders | 7.88% |
| % Held by Institutions | 101.45% |
| 52 Weeks Range | ||
| Price Target Range | ||
| High | 200.00 (Piper Sandler, 31.86%) | Buy |
| Median | 190.00 (25.26%) | |
| Low | 185.00 (Raymond James, 21.97%) | Buy |
| Average | 191.67 (26.37%) | |
| Total | 3 Buy | |
| Avg. Price @ Call | 150.11 | |
| Firm | Date | Target Price | Call | Price @ Call |
|---|---|---|---|---|
| Piper Sandler | 07 May 2025 | 200.00 (31.86%) | Buy | 150.11 |
| Raymond James | 07 May 2025 | 185.00 (21.97%) | Buy | 150.11 |
| Wells Fargo | 07 May 2025 | 190.00 (25.26%) | Buy | 150.11 |
No data within this time range.
| Date | Type | Details |
|---|---|---|
| 10 Jun 2025 | Announcement | New Study Finds Masimo SedLine® Brain Function Monitoring Offers Significant Advantages During Pediatric Anesthesia |
| 07 May 2025 | Announcement | Masimo to Present in the BofA Securities 2025 Health Care Conference |
| 06 May 2025 | Announcement | Masimo Reports First Quarter 2025 Results |
| 06 May 2025 | Announcement | Masimo to Sell Consumer Audio Business to HARMAN International |
| 24 Apr 2025 | Announcement | Masimo to Report First Quarter 2025 Financial Results after Market Close on Tuesday, May 6 |
| 02 Apr 2025 | Announcement | Masimo to Present in the 24th Annual Needham Virtual Healthcare Conference |
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2025 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |